Similar articles for PMID: 17509926

Year	Number of Results
1958	1
1989	3
1993	1
1997	1
1998	1
2000	1
2001	1
2002	1
2003	3
2004	9
2005	2
2006	4
2007	19
2008	12
2009	15
2010	4
2011	3
2012	3
2013	2
2014	2
2015	6
2016	10
2017	7
2018	3
2019	5
2020	3
2021	2
2022	1
2023	2
2024	0

1

Interleukin-21: a new modulator of immunity, infection, and cancer.

Brandt K, Singh PB, Bulfone-Paus S, Rückert R. Brandt K, et al. Cytokine Growth Factor Rev. 2007 Jun-Aug;18(3-4):223-32. doi: 10.1016/j.cytogfr.2007.04.003. Epub 2007 May 16. Cytokine Growth Factor Rev. 2007. PMID: 17509926 Review.

2

Interleukin-21 signaling: functions in cancer and autoimmunity.

Davis ID, Skak K, Smyth MJ, Kristjansen PE, Miller DM, Sivakumar PV. Davis ID, et al. Clin Cancer Res. 2007 Dec 1;13(23):6926-32. doi: 10.1158/1078-0432.CCR-07-1238. Clin Cancer Res. 2007. PMID: 18056166 Review.

3

Biology of IL-21 and the IL-21 receptor.

Mehta DS, Wurster AL, Grusby MJ. Mehta DS, et al. Immunol Rev. 2004 Dec;202:84-95. doi: 10.1111/j.0105-2896.2004.00201.x. Immunol Rev. 2004. PMID: 15546387 Review.

4

IL-21: a novel IL-2-family lymphokine that modulates B, T, and natural killer cell responses.

Habib T, Nelson A, Kaushansky K. Habib T, et al. J Allergy Clin Immunol. 2003 Dec;112(6):1033-45. doi: 10.1016/j.jaci.2003.08.039. J Allergy Clin Immunol. 2003. PMID: 14657853 Review.

5

Interleukin-21 and the IL-21 receptor: novel effectors of NK and T cell responses.

Parrish-Novak J, Foster DC, Holly RD, Clegg CH. Parrish-Novak J, et al. J Leukoc Biol. 2002 Nov;72(5):856-63. J Leukoc Biol. 2002. PMID: 12429707 Review.

6

IL-21: roles in immunopathology and cancer therapy.

Søndergaard H, Skak K. Søndergaard H, et al. Tissue Antigens. 2009 Dec;74(6):467-79. doi: 10.1111/j.1399-0039.2009.01382.x. Epub 2009 Oct 21. Tissue Antigens. 2009. PMID: 19845910 Review.

7

IL-12 and IL-23: master regulators of innate and adaptive immunity.

Langrish CL, McKenzie BS, Wilson NJ, de Waal Malefyt R, Kastelein RA, Cua DJ. Langrish CL, et al. Immunol Rev. 2004 Dec;202:96-105. doi: 10.1111/j.0105-2896.2004.00214.x. Immunol Rev. 2004. PMID: 15546388 Review.

8

Endogenous IL-21 restricts CD8+ T cell expansion and is not required for tumor immunity.

Søndergaard H, Coquet JM, Uldrich AP, McLaughlin N, Godfrey DI, Sivakumar PV, Skak K, Smyth MJ. Søndergaard H, et al. J Immunol. 2009 Dec 1;183(11):7326-36. doi: 10.4049/jimmunol.0902697. Epub 2009 Nov 13. J Immunol. 2009. PMID: 19915059

9

Interleukin-22: a novel T- and NK-cell derived cytokine that regulates the biology of tissue cells.

Wolk K, Sabat R. Wolk K, et al. Cytokine Growth Factor Rev. 2006 Oct;17(5):367-80. doi: 10.1016/j.cytogfr.2006.09.001. Epub 2006 Oct 9. Cytokine Growth Factor Rev. 2006. PMID: 17030002 Review.

10

A positive feedback loop of IL-21 signaling provoked by homeostatic CD4+CD25- T cell expansion is essential for the development of arthritis in autoimmune K/BxN mice.

Jang E, Cho SH, Park H, Paik DJ, Kim JM, Youn J. Jang E, et al. J Immunol. 2009 Apr 15;182(8):4649-56. doi: 10.4049/jimmunol.0804350. J Immunol. 2009. PMID: 19342640

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

117 results

Results by year